Before the market open, the Louisville, KY-based health insurer posted adjusted earnings of $3.18 per share on revenue of $13.69 billion.
Analysts surveyed by FactSet had projected earnings of $3.00 per share on revenue of $13.41 billion.
For 2016, Humana continues to see adjusted earnings of about $9.50 per share. Analysts are expecting earnings of $9.32 per share for the full year, according to FactSet.
The company is seeking regulatory approval for its merger with rival insurer Aetna (AET).
Shares of Humana closed down on Thursday.
Separately, TheStreet Ratings Team has a "Buy" rating with a score of B+ on the stock.
The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations.
The team believes its strengths outweigh the fact that the company has had sub par growth in net income.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
You can view the full analysis from the report here: HUM